Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox‐9 transcription factor

Objective. To investigate the effects of culture conditions, serum and specific cytokines such as insulin‐like growth factor (IGF) 1 and interleukin (IL) 1α on phenotype and cell survival in cultures of Syrian hamster embryonic chondrocyte‐like cells (DES4+.2). Methods. Proteins and RNA extracted fr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Rheumatology (Oxford, England) England), 2001-10, Vol.40 (10), p.1146-1156
Hauptverfasser: Kolettas, E., Muir, H. I., Barrett, J. C., Hardingham, T. E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1156
container_issue 10
container_start_page 1146
container_title Rheumatology (Oxford, England)
container_volume 40
creator Kolettas, E.
Muir, H. I.
Barrett, J. C.
Hardingham, T. E.
description Objective. To investigate the effects of culture conditions, serum and specific cytokines such as insulin‐like growth factor (IGF) 1 and interleukin (IL) 1α on phenotype and cell survival in cultures of Syrian hamster embryonic chondrocyte‐like cells (DES4+.2). Methods. Proteins and RNA extracted from subconfluent and confluent early‐ and late‐passage DES4+.2 cells cultured in the presence or absence of serum and IL‐1α or IGF‐1 or both cytokines together were analysed for the expression of chondrocyte‐specific genes and for the chondrogenic transcription factor Sox‐9 by Western and Northern blotting. Apoptosis was assessed by agarose gel electrophoresis of labelled low‐molecular weight DNA extracted from DES4+.2 cells and another Syrian hamster embryonic chondrocyte‐like cell line, 10W+.1, cultured under the different conditions and treatments. Results. Early passage DES4+.2 cells expressed chondrocyte‐specific molecules such as collagen types α1(II) and α1(IX), aggrecan, biglycan and link protein and collagen types α1(I) and α1(X) mRNAs, suggesting a prehypertrophic chondrocyte‐like phenotype. The expression of all genes investigated was cell density‐ and serum‐dependent and was low to undetectable in cell populations from later passages. Early‐passage DES4+.2 and 10W+.1 cells survived when cultured at low cell density, but died by apoptosis when cultured at high cell density in the absence of serum or IGF‐1. IGF‐1 and IL‐1α had opposite and antagonistic effects on the chondrocyte phenotype and survival. Whereas IL‐1α acting alone suppressed cartilage‐specific gene expression without significantly affecting cell survival, IGF‐1 increased the steady‐state mRNA levels and relieved the IL‐1α‐induced suppression of all the chondrocyte‐specific genes investigated; it also enhanced chondrocyte survival. Suppression of the chondrocyte phenotype by the inflammatory cytokine IL‐1α correlated with marked down‐regulation of the transcription factor Sox‐9, which was relieved by IGF‐1. The expression of the Sox9 gene was closely correlated with the expression of the chondrocyte‐specific genes under all conditions and treatments. Conclusions. The results suggest that the effects of cartilage anabolic and catabolic cytokines IGF‐1 and IL‐1α on the expression of the chondrocyte phenotype are mediated by Sox‐9. As Sox‐9 appears to be essential for matrix production, the potent effect of IL‐1α in suppressing Sox‐9 expression may limit the ability of cartilage to repair dur
doi_str_mv 10.1093/rheumatology/40.10.1146
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20520953</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>546028571</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-6084231d7c1e7079de9f210f5b3fbaab228d85fe69260c02d53593366202dd4e3</originalsourceid><addsrcrecordid>eNpdkd1u1DAQhSMEoj_wCmAhwV1a_ye5RCugSBUIsUiIG8txJhu32TjYTrW56yPwADwdT4LTXbWImxlr5jtHtk-WvST4jOCKnfsOpq2Orneb-ZwvwzNCuHyUHadKc8wYfXx_pvwoOwnhCmMsCCufZkeESIwLLo6z36vODY13Zo6Axg4GF-cRkB4aZKDvUZj8jb3RPdIekIfN1OsIDapnZKY-Tmlokt5G64Zwp0qbMIKxrTUombprO0BAsfNu2nSpA4Ld6CGEpECuRV_d7s_trwpFr4dgvB0XK9RqE51_lj1pdR_g-aGfZt_ev1uvLvLLzx8-rt5e5oaXPOYSl5wy0hSGQIGLqoGqpQS3omZtrXVNadmUogVZUYkNpo1gomJMSprODQd2mr3Z-47e_ZwgRLW1YXm-HsBNQVEsKK4ES-Cr_8ArN_kh3U2RSsiiTCVBxR4y3oXgoVWjt1vtZ0WwWtJT_6anOL6bp6yS8sXBfqq30DzoDnEl4PUB0MHovk1_Zmx44DguiwovXL7nbIiwu99rf61kwQqhLr7_UHwtqFyTL-oT-wvq5ro3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195678956</pqid></control><display><type>article</type><title>Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox‐9 transcription factor</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Kolettas, E. ; Muir, H. I. ; Barrett, J. C. ; Hardingham, T. E.</creator><creatorcontrib>Kolettas, E. ; Muir, H. I. ; Barrett, J. C. ; Hardingham, T. E.</creatorcontrib><description>Objective. To investigate the effects of culture conditions, serum and specific cytokines such as insulin‐like growth factor (IGF) 1 and interleukin (IL) 1α on phenotype and cell survival in cultures of Syrian hamster embryonic chondrocyte‐like cells (DES4+.2). Methods. Proteins and RNA extracted from subconfluent and confluent early‐ and late‐passage DES4+.2 cells cultured in the presence or absence of serum and IL‐1α or IGF‐1 or both cytokines together were analysed for the expression of chondrocyte‐specific genes and for the chondrogenic transcription factor Sox‐9 by Western and Northern blotting. Apoptosis was assessed by agarose gel electrophoresis of labelled low‐molecular weight DNA extracted from DES4+.2 cells and another Syrian hamster embryonic chondrocyte‐like cell line, 10W+.1, cultured under the different conditions and treatments. Results. Early passage DES4+.2 cells expressed chondrocyte‐specific molecules such as collagen types α1(II) and α1(IX), aggrecan, biglycan and link protein and collagen types α1(I) and α1(X) mRNAs, suggesting a prehypertrophic chondrocyte‐like phenotype. The expression of all genes investigated was cell density‐ and serum‐dependent and was low to undetectable in cell populations from later passages. Early‐passage DES4+.2 and 10W+.1 cells survived when cultured at low cell density, but died by apoptosis when cultured at high cell density in the absence of serum or IGF‐1. IGF‐1 and IL‐1α had opposite and antagonistic effects on the chondrocyte phenotype and survival. Whereas IL‐1α acting alone suppressed cartilage‐specific gene expression without significantly affecting cell survival, IGF‐1 increased the steady‐state mRNA levels and relieved the IL‐1α‐induced suppression of all the chondrocyte‐specific genes investigated; it also enhanced chondrocyte survival. Suppression of the chondrocyte phenotype by the inflammatory cytokine IL‐1α correlated with marked down‐regulation of the transcription factor Sox‐9, which was relieved by IGF‐1. The expression of the Sox9 gene was closely correlated with the expression of the chondrocyte‐specific genes under all conditions and treatments. Conclusions. The results suggest that the effects of cartilage anabolic and catabolic cytokines IGF‐1 and IL‐1α on the expression of the chondrocyte phenotype are mediated by Sox‐9. As Sox‐9 appears to be essential for matrix production, the potent effect of IL‐1α in suppressing Sox‐9 expression may limit the ability of cartilage to repair during inflammatory joint diseases.</description><identifier>ISSN: 1462-0324</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/40.10.1146</identifier><identifier>PMID: 11600745</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Aggrecans ; Animals ; Antimetabolites, Antineoplastic - pharmacology ; Apoptosis ; Apoptosis - drug effects ; Apoptosis - immunology ; Azacitidine - pharmacology ; Biglycan ; Biological and medical sciences ; Cell Line, Transformed ; Cell Survival - immunology ; Chondrocytes ; Chondrocytes - cytology ; Chondrocytes - immunology ; Collagen Type II - genetics ; Collagen Type IX - genetics ; Cricetinae ; Cytokines ; Extracellular Matrix Proteins ; Fetus - cytology ; Fundamental and applied biological sciences. Psychology ; Gene expression ; Gene Expression - drug effects ; Gene Expression - immunology ; High Mobility Group Proteins - genetics ; High Mobility Group Proteins - immunology ; Insulin-Like Growth Factor I - pharmacology ; Interleukin-1 - pharmacology ; Lectins, C-Type ; Mesocricetus ; Phenotype ; Proteins - genetics ; Proteoglycans - genetics ; RNA, Messenger - analysis ; Skeleton and joints ; Sox9 ; SOX9 Transcription Factor ; Transcription Factors - genetics ; Transcription Factors - immunology ; Vertebrates: osteoarticular system, musculoskeletal system</subject><ispartof>Rheumatology (Oxford, England), 2001-10, Vol.40 (10), p.1146-1156</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) Oct 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-6084231d7c1e7079de9f210f5b3fbaab228d85fe69260c02d53593366202dd4e3</citedby><cites>FETCH-LOGICAL-c484t-6084231d7c1e7079de9f210f5b3fbaab228d85fe69260c02d53593366202dd4e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14087905$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11600745$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kolettas, E.</creatorcontrib><creatorcontrib>Muir, H. I.</creatorcontrib><creatorcontrib>Barrett, J. C.</creatorcontrib><creatorcontrib>Hardingham, T. E.</creatorcontrib><title>Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox‐9 transcription factor</title><title>Rheumatology (Oxford, England)</title><addtitle>Rheumatology</addtitle><description>Objective. To investigate the effects of culture conditions, serum and specific cytokines such as insulin‐like growth factor (IGF) 1 and interleukin (IL) 1α on phenotype and cell survival in cultures of Syrian hamster embryonic chondrocyte‐like cells (DES4+.2). Methods. Proteins and RNA extracted from subconfluent and confluent early‐ and late‐passage DES4+.2 cells cultured in the presence or absence of serum and IL‐1α or IGF‐1 or both cytokines together were analysed for the expression of chondrocyte‐specific genes and for the chondrogenic transcription factor Sox‐9 by Western and Northern blotting. Apoptosis was assessed by agarose gel electrophoresis of labelled low‐molecular weight DNA extracted from DES4+.2 cells and another Syrian hamster embryonic chondrocyte‐like cell line, 10W+.1, cultured under the different conditions and treatments. Results. Early passage DES4+.2 cells expressed chondrocyte‐specific molecules such as collagen types α1(II) and α1(IX), aggrecan, biglycan and link protein and collagen types α1(I) and α1(X) mRNAs, suggesting a prehypertrophic chondrocyte‐like phenotype. The expression of all genes investigated was cell density‐ and serum‐dependent and was low to undetectable in cell populations from later passages. Early‐passage DES4+.2 and 10W+.1 cells survived when cultured at low cell density, but died by apoptosis when cultured at high cell density in the absence of serum or IGF‐1. IGF‐1 and IL‐1α had opposite and antagonistic effects on the chondrocyte phenotype and survival. Whereas IL‐1α acting alone suppressed cartilage‐specific gene expression without significantly affecting cell survival, IGF‐1 increased the steady‐state mRNA levels and relieved the IL‐1α‐induced suppression of all the chondrocyte‐specific genes investigated; it also enhanced chondrocyte survival. Suppression of the chondrocyte phenotype by the inflammatory cytokine IL‐1α correlated with marked down‐regulation of the transcription factor Sox‐9, which was relieved by IGF‐1. The expression of the Sox9 gene was closely correlated with the expression of the chondrocyte‐specific genes under all conditions and treatments. Conclusions. The results suggest that the effects of cartilage anabolic and catabolic cytokines IGF‐1 and IL‐1α on the expression of the chondrocyte phenotype are mediated by Sox‐9. As Sox‐9 appears to be essential for matrix production, the potent effect of IL‐1α in suppressing Sox‐9 expression may limit the ability of cartilage to repair during inflammatory joint diseases.</description><subject>Aggrecans</subject><subject>Animals</subject><subject>Antimetabolites, Antineoplastic - pharmacology</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis - immunology</subject><subject>Azacitidine - pharmacology</subject><subject>Biglycan</subject><subject>Biological and medical sciences</subject><subject>Cell Line, Transformed</subject><subject>Cell Survival - immunology</subject><subject>Chondrocytes</subject><subject>Chondrocytes - cytology</subject><subject>Chondrocytes - immunology</subject><subject>Collagen Type II - genetics</subject><subject>Collagen Type IX - genetics</subject><subject>Cricetinae</subject><subject>Cytokines</subject><subject>Extracellular Matrix Proteins</subject><subject>Fetus - cytology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene expression</subject><subject>Gene Expression - drug effects</subject><subject>Gene Expression - immunology</subject><subject>High Mobility Group Proteins - genetics</subject><subject>High Mobility Group Proteins - immunology</subject><subject>Insulin-Like Growth Factor I - pharmacology</subject><subject>Interleukin-1 - pharmacology</subject><subject>Lectins, C-Type</subject><subject>Mesocricetus</subject><subject>Phenotype</subject><subject>Proteins - genetics</subject><subject>Proteoglycans - genetics</subject><subject>RNA, Messenger - analysis</subject><subject>Skeleton and joints</subject><subject>Sox9</subject><subject>SOX9 Transcription Factor</subject><subject>Transcription Factors - genetics</subject><subject>Transcription Factors - immunology</subject><subject>Vertebrates: osteoarticular system, musculoskeletal system</subject><issn>1462-0324</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkd1u1DAQhSMEoj_wCmAhwV1a_ye5RCugSBUIsUiIG8txJhu32TjYTrW56yPwADwdT4LTXbWImxlr5jtHtk-WvST4jOCKnfsOpq2Orneb-ZwvwzNCuHyUHadKc8wYfXx_pvwoOwnhCmMsCCufZkeESIwLLo6z36vODY13Zo6Axg4GF-cRkB4aZKDvUZj8jb3RPdIekIfN1OsIDapnZKY-Tmlokt5G64Zwp0qbMIKxrTUombprO0BAsfNu2nSpA4Ld6CGEpECuRV_d7s_trwpFr4dgvB0XK9RqE51_lj1pdR_g-aGfZt_ev1uvLvLLzx8-rt5e5oaXPOYSl5wy0hSGQIGLqoGqpQS3omZtrXVNadmUogVZUYkNpo1gomJMSprODQd2mr3Z-47e_ZwgRLW1YXm-HsBNQVEsKK4ES-Cr_8ArN_kh3U2RSsiiTCVBxR4y3oXgoVWjt1vtZ0WwWtJT_6anOL6bp6yS8sXBfqq30DzoDnEl4PUB0MHovk1_Zmx44DguiwovXL7nbIiwu99rf61kwQqhLr7_UHwtqFyTL-oT-wvq5ro3</recordid><startdate>20011001</startdate><enddate>20011001</enddate><creator>Kolettas, E.</creator><creator>Muir, H. I.</creator><creator>Barrett, J. C.</creator><creator>Hardingham, T. E.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20011001</creationdate><title>Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox‐9 transcription factor</title><author>Kolettas, E. ; Muir, H. I. ; Barrett, J. C. ; Hardingham, T. E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-6084231d7c1e7079de9f210f5b3fbaab228d85fe69260c02d53593366202dd4e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Aggrecans</topic><topic>Animals</topic><topic>Antimetabolites, Antineoplastic - pharmacology</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis - immunology</topic><topic>Azacitidine - pharmacology</topic><topic>Biglycan</topic><topic>Biological and medical sciences</topic><topic>Cell Line, Transformed</topic><topic>Cell Survival - immunology</topic><topic>Chondrocytes</topic><topic>Chondrocytes - cytology</topic><topic>Chondrocytes - immunology</topic><topic>Collagen Type II - genetics</topic><topic>Collagen Type IX - genetics</topic><topic>Cricetinae</topic><topic>Cytokines</topic><topic>Extracellular Matrix Proteins</topic><topic>Fetus - cytology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene expression</topic><topic>Gene Expression - drug effects</topic><topic>Gene Expression - immunology</topic><topic>High Mobility Group Proteins - genetics</topic><topic>High Mobility Group Proteins - immunology</topic><topic>Insulin-Like Growth Factor I - pharmacology</topic><topic>Interleukin-1 - pharmacology</topic><topic>Lectins, C-Type</topic><topic>Mesocricetus</topic><topic>Phenotype</topic><topic>Proteins - genetics</topic><topic>Proteoglycans - genetics</topic><topic>RNA, Messenger - analysis</topic><topic>Skeleton and joints</topic><topic>Sox9</topic><topic>SOX9 Transcription Factor</topic><topic>Transcription Factors - genetics</topic><topic>Transcription Factors - immunology</topic><topic>Vertebrates: osteoarticular system, musculoskeletal system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kolettas, E.</creatorcontrib><creatorcontrib>Muir, H. I.</creatorcontrib><creatorcontrib>Barrett, J. C.</creatorcontrib><creatorcontrib>Hardingham, T. E.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kolettas, E.</au><au>Muir, H. I.</au><au>Barrett, J. C.</au><au>Hardingham, T. E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox‐9 transcription factor</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><addtitle>Rheumatology</addtitle><date>2001-10-01</date><risdate>2001</risdate><volume>40</volume><issue>10</issue><spage>1146</spage><epage>1156</epage><pages>1146-1156</pages><issn>1462-0324</issn><eissn>1462-0332</eissn><abstract>Objective. To investigate the effects of culture conditions, serum and specific cytokines such as insulin‐like growth factor (IGF) 1 and interleukin (IL) 1α on phenotype and cell survival in cultures of Syrian hamster embryonic chondrocyte‐like cells (DES4+.2). Methods. Proteins and RNA extracted from subconfluent and confluent early‐ and late‐passage DES4+.2 cells cultured in the presence or absence of serum and IL‐1α or IGF‐1 or both cytokines together were analysed for the expression of chondrocyte‐specific genes and for the chondrogenic transcription factor Sox‐9 by Western and Northern blotting. Apoptosis was assessed by agarose gel electrophoresis of labelled low‐molecular weight DNA extracted from DES4+.2 cells and another Syrian hamster embryonic chondrocyte‐like cell line, 10W+.1, cultured under the different conditions and treatments. Results. Early passage DES4+.2 cells expressed chondrocyte‐specific molecules such as collagen types α1(II) and α1(IX), aggrecan, biglycan and link protein and collagen types α1(I) and α1(X) mRNAs, suggesting a prehypertrophic chondrocyte‐like phenotype. The expression of all genes investigated was cell density‐ and serum‐dependent and was low to undetectable in cell populations from later passages. Early‐passage DES4+.2 and 10W+.1 cells survived when cultured at low cell density, but died by apoptosis when cultured at high cell density in the absence of serum or IGF‐1. IGF‐1 and IL‐1α had opposite and antagonistic effects on the chondrocyte phenotype and survival. Whereas IL‐1α acting alone suppressed cartilage‐specific gene expression without significantly affecting cell survival, IGF‐1 increased the steady‐state mRNA levels and relieved the IL‐1α‐induced suppression of all the chondrocyte‐specific genes investigated; it also enhanced chondrocyte survival. Suppression of the chondrocyte phenotype by the inflammatory cytokine IL‐1α correlated with marked down‐regulation of the transcription factor Sox‐9, which was relieved by IGF‐1. The expression of the Sox9 gene was closely correlated with the expression of the chondrocyte‐specific genes under all conditions and treatments. Conclusions. The results suggest that the effects of cartilage anabolic and catabolic cytokines IGF‐1 and IL‐1α on the expression of the chondrocyte phenotype are mediated by Sox‐9. As Sox‐9 appears to be essential for matrix production, the potent effect of IL‐1α in suppressing Sox‐9 expression may limit the ability of cartilage to repair during inflammatory joint diseases.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>11600745</pmid><doi>10.1093/rheumatology/40.10.1146</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1462-0324
ispartof Rheumatology (Oxford, England), 2001-10, Vol.40 (10), p.1146-1156
issn 1462-0324
1462-0332
language eng
recordid cdi_proquest_miscellaneous_20520953
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Alma/SFX Local Collection
subjects Aggrecans
Animals
Antimetabolites, Antineoplastic - pharmacology
Apoptosis
Apoptosis - drug effects
Apoptosis - immunology
Azacitidine - pharmacology
Biglycan
Biological and medical sciences
Cell Line, Transformed
Cell Survival - immunology
Chondrocytes
Chondrocytes - cytology
Chondrocytes - immunology
Collagen Type II - genetics
Collagen Type IX - genetics
Cricetinae
Cytokines
Extracellular Matrix Proteins
Fetus - cytology
Fundamental and applied biological sciences. Psychology
Gene expression
Gene Expression - drug effects
Gene Expression - immunology
High Mobility Group Proteins - genetics
High Mobility Group Proteins - immunology
Insulin-Like Growth Factor I - pharmacology
Interleukin-1 - pharmacology
Lectins, C-Type
Mesocricetus
Phenotype
Proteins - genetics
Proteoglycans - genetics
RNA, Messenger - analysis
Skeleton and joints
Sox9
SOX9 Transcription Factor
Transcription Factors - genetics
Transcription Factors - immunology
Vertebrates: osteoarticular system, musculoskeletal system
title Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox‐9 transcription factor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T13%3A34%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chondrocyte%20phenotype%20and%20cell%20survival%20are%20regulated%20by%20culture%20conditions%20and%20by%20specific%20cytokines%20through%20the%20expression%20of%20Sox%E2%80%909%20transcription%20factor&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=Kolettas,%20E.&rft.date=2001-10-01&rft.volume=40&rft.issue=10&rft.spage=1146&rft.epage=1156&rft.pages=1146-1156&rft.issn=1462-0324&rft.eissn=1462-0332&rft_id=info:doi/10.1093/rheumatology/40.10.1146&rft_dat=%3Cproquest_cross%3E546028571%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=195678956&rft_id=info:pmid/11600745&rfr_iscdi=true